Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in bilateral nasal polyposis on background intranasal corticosteroids
2015-001314-10Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Dupilumab + MFNS with Placebo + MFNS (2 arms). Primary endpoints: Change from baseline in nasal congestion/obstruction symptom severity score, Change from baseline in endoscopic nasal polyposis score and 1 more. Started Sep 2016; status: completed.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on 2015-001314-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001314-10.